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Abstract Different neuroimaging techniques (fMRI,
spectroscopy, PET) are being used to evaluate candidate
drugs in pharmacological development. In patients with
epilepsy fast propagation of the epileptiform activity
between different brain areas occurs. Electric Source
Imaging (ESI), in contrast to the aforementioned tech-
niques, has a millisecond time resolution, allowing visu-
alization of this fast propagation. The purpose of the
current project was to use ESI to investigate whether
introduction of an antiepileptic drug (levetiracetam, LEV)
would change the propagation patterns of the interictal
epileptiform activity. Thirty patients with epilepsy were
subject to an EEG recording before (pre-LEV) and after
(in-LEV) introduction of LEV. Interictal spikes with sim-
ilar topographic distribution were averaged within each
subject, and a distributed source model was used to localize
the EEG sources of the epileptiform activity. The temporal
development of the activity within 20 regions of interest
(ROIs) was determined, and source propagation between
different regions was compared between the pre-LEV and
in-LEV recordings. Patients with epileptic seizures showed
propagation in 22/24 identified spike types in the pre-LEV
recordings. In the in-LEV recordings only 7/15 spike types
showed propagation, and six of these seven propagating
spikes were recorded in patients with poor effect of treat-
ment. Also in patients without seizures LEV tended to
suppress propagation. We conclude that the observed
suppression of source propagation can be considered as an
indicator of effective antiepileptic treatment. ESI might
thus become a useful tool in the early clinical evaluation of
new candidate drugs in pharmacological development.
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Introduction
In the evaluation of candidate drugs for neuropharmaco-
logical treatment, different neuroimaging techniques such
as fMRI, NMR spectroscopy and PET have been used (Lee
and Farde 2006; Borsook et al. 2006; Pellecchia et al. 2002;
Wise and Tracey 2006). The key to success in drug
development is to target the drugs to the main pathophys-
iological process (Spedding 2006). In patients with epi-
lepsy, propagation of the epileptiform activity is likely to
be an important factor for the development of clinical
symptoms (Duncan et al. 2006; Elger and Schmidt 2008;
Lehnertz et al. 2009). Fast spread of the epileptiform
activity can occur, both within the temporal lobe and
between distant areas (Alarcon et al. 1994, 1997; Emerson
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et al. 1995; Lantz et al. 2003b; Merlet et al. 1996; Suth-
erling and Barth 1989). The possibility to disentangle the
temporal sequence of these complex activation patterns
may be of considerable importance for understanding the
epileptic process and for assessing the potential effective-
ness of a certain candidate drug. Unfortunately, this
important feature of the epileptic disorder is not easily
visualized with hemodynamic methods, due to their
inherently limited temporal resolution. On the other hand,
several studies have demonstrated that it is indeed possible
to visualize this propagation using modern quantitative
EEG analysis techniques (Ebersole et al. 1995; Fuchs et al.
1999; Huppertz et al. 2001; Lantz et al. 2003b; Scherg et al.
1999; Michel et al. 1999).
Pharmaco-EEG has traditionally been one tool in studies
of drug effects (Itil 1982; Saletu et al. 1987; Wauquier 2005).
In recent years there has been a considerable methodological
development concerning quantification and localization of
brain electric activity (EEG) (for a review see, Michel et al.
2004b). Source reconstruction procedures, known as Electric
Source Imaging (ESI), have found important applications
both in research, trying to assess normal functions of the
brain (sensory functions, cognition, for a review see (Michel
et al. 2001)), and in patient oriented clinical research, espe-
cially epilepsy (Ebersole 1991; Fuchs et al. 1999; Lantz et al.
2003a, b, 1997, 1999; Merlet and Gotman 1999; Scherg et al.
1999; Sperli et al. 2006; Michel et al. 1999, 2004a). So far,
however, few investigators have applied these new analysis
methods in drug assessment studies.
The purpose of the current study was to evaluate whe-
ther ESI could be used to extract features from the inter-
ictal epileptiform activity that could be used as markers for
effective antiepileptic treatment. Given the known ten-
dency of interictal spikes to propagate between different
brain areas we considered this an appropriate feature to
study. Propagation of epileptiform activity between distant
brain areas is likely to be an important pathophysiological
factor for the development of epileptic seizures (Bikson
et al. 2003; Jefferys 2003; Pfurtscheller and Silva 1999;
Suffczynski et al. 2001), and for this reason the faculty of
an antiepileptic drug (AED) to suppress the tendency of a
spike to propagate would be a strong indicator of efficacy.
Consequently, if ESI could be shown to be capable of
visualizing such a suppression of propagation, it would
yield useful information about the change in brain con-
nectivity due to the introduction of a specific AED. The
hypothesis was that it should be possible (a) to visualize
propagation of interictal epileptiform activity in a group of
patients with no or inadequate antiepileptic medication,
and (b) to document a change in these propagation patterns
after introduction of an AED, in this case levetiracetam,
that on clinical/electrophysiological grounds was consid-
ered to be efficient in a specific patient.
Patients and Methods
All patients (about 500) in our database with Focal Noc-
turnal Epileptiform Activity (FNEA) were reviewed.
FNEA was defined as sleep enhanced focal epileptiform
activity with a spike index above 30 (Larsson et al. 2009).
From this group of patients, 30 fulfilling the following
criteria were identified and included in the study: The
patients should have been subject to two separate EEG
recordings, one before (pre-LEV) and one after (in-LEV)
introduction of levetiracetam (LEV), and they should be on
LEV monotherapy during the in-LEV investigation. Of the
30 patients (21 males, 9 females, aged 4–14, mean 9 years)
seventeen also had a history of focal epileptic seizures.
Thirteen patients did not have seizures, but had ambulatory
recording either due to unclear episodes or for quantifica-
tion of FNEA. LEV was initiated due to the FNEA. The
pre-LEV recording was performed between 0 and 8 (mean
0.7) months before introduction of LEV, and the in-LEV
recording was performed between 2 and 31 (mean 6)
months after introduction of the drug. At the time of the
pre-LEV investigation, 19 of the patients were without
antiepileptic drug medication, whereas 11 patients were
treated with other AEDs (see Table 1). At the time of the
in-LEV investigation none of the patient was treated with
any other AED drug.
The EEG recordings were performed using one of three
different recording systems: (1) An Embla-system with
16 recording electrodes placed according to the 10–20
system except Fz,Cz and Pz. (2) A Track-it system with
19 recording electrodes placed according to the 10–20
system. (3) A NicOne system with 25 recording elec-
trodes (‘‘low rows’’ F9, T9, P9, F10, T10, P10 added).
Before further processing, data from the different systems
were standardized to the same 16 channel electrode con-
figuration and downsampled to 100 Hz. The data was fil-
tered off line with LFF 2 Hz, and HFF 30 Hz.
In each patient the two different EEG recordings were
reviewed. Two hours of EEG, recorded just after the patient
had fallen asleep, was scanned using the pattern recognition
feature of the BESA system in order to identify different
interictal epileptiform potentials with different surface
voltage distributions. With this algorithm, spikes are
detected by template matching of the principal components
derived from the current source density estimate of the
patients’ EEG. Between one and three different surface
distributions were identified in each investigation, and all
the individual spikes or sharp waves of a certain distribution
were averaged. These different surface distributions are in
this manuscript referred to as spike types. The number of
potentials averaged ranged between 85 and 9198 (mean
2824). Although not all spikes in the EEG were recognized
by the analysis program, it was assured, through visual
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inspection of the traces, that no significant distributions had
been overseen by the pattern recognition algorithm. In a few
patients in whom the epileptiform activity was of too low
amplitude to be reliably detected by the algorithm, the spike
identification was performed manually.
A distributed source model (Radially Weighted Mini-
mum Norm; Grave de Peralta Menendez and Gonzalez
Andino 1998) was used to model the distribution of the
electric activity within the brain during different phases of
the spike or sharp wave. The solution space for the inverse
solution, consisted of 3005 solution points, which were
regularly distributed in the standard brain provided by the
Montreal Neurological Institute (MNI). A spherical head
model with anatomical constraints (SMAC; Spinelli et al.
2000) which transforms the MRI to the best fitting sphere,
was used. The solution space was divided into 20 regions
of interest (ROIs), and the average source activity of all
solution points within a ROI was calculated for each time
point during the course of a spike or a sharp wave. In this
way the development of the activity within each ROI could
be followed over time (Fig. 1). To avoid contamination
from background noise only ROIs with a peak power of at
least 25% of that of the region with the maximal power
were considered to show a significant activation.
For each patient the number of spikes, and the maximum
source amplitude of the averaged spike, was compared
between the pre-LEV and in-LEV investigations. Reduc-
tion in number of spikes and reduction of source amplitude
between the two investigations, together with the clinical
judgment of whether the patient was optimally treated on
LEV monotherapy, was then used as indicators of treat-
ment efficacy (Table 1).
Subsequently, the time course of the reconstructed cor-
tical activation within the different ROIs were inspected,
Table 1 Effect of LEV introduction on different EEG parameters in all patients
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and the delay between the activity peak in the ROI of
primary activation and that of the other ROIs was mea-
sured, and interpreted in terms of propagation between the
different brain regions. Then, for each patient, any change
in spike propagation from the pre-LEV to the in-LEV study
(Table 2) was assessed and related to the three other
indicators of treatment efficacy (spike number, source
amplitude, and clinical yield, Table 1).
Results
Patients with a History of Epileptic Seizures
Seventeen of the 30 patients had a history of epileptic
seizures. In these 17 patients, a total of 24 different spike
types were obtained in the pre-LEV investigations
(Table 2). In 22 of these 24 spike types source localization
revealed a time lag of 10–50 ms between the peak activity
of the primary source and that of one or several other
regions (Fig. 2).
In five of the 17 patients (pats 1–5) the epileptiform
activity completely disappeared after introduction of LEV
(Table 1). In one patient (Pat 11) epileptiform activity
remained in a first but disappeared in a subsequent
recording without changing the dose of the drug. In another
five patients (pats 6–10) introduction of the drug lead to
marked reduction in spike index (on the average—73%)
and/or source amplitude (on the average—64%). These
eleven patients were all considered to be optimally treated
with LEV monotherapy.
In the five patients with remaining spikes but with a
marked reduction in spike index/amplitude (pats 6–10),
seven different spike types were encountered in the in-LEV
Fig. 1 The analysis procedure. a From the raw EEG spikes are
identified. b Several spikes with a similar distribution are averaged.
c A source reconstruction is performed for several time points
throughout the spike-wave complex. d The solution space of the
inverse solution is divided into 20 Regions of Interest (ROIs). e The
average estimated current density of all solution points within a ROI
is calculated and the time course of the average current density within
each ROI is displayed
272 Brain Topogr (2010) 23:269–278
123
recordings but for only one of these spikes was propagation
between different areas seen (Pat 9, Table 2). Conse-
quently, in cases where introduction of the drug did not
suppress the epileptiform activity completely, the remain-
ing epileptiform activity was not only less frequent and
lower in amplitude compared to the pre-LEV study, but
was also almost completely void of the tendency to prop-
agate between different regions that had been observed in
the pre-LEV investigations.
In six of the 17 patients with a seizure history (pats
12–17) the results were less clear. In these patients either
the spike frequency, source amplitude or both remained
unchanged or even increased after introduction of LEV
treatment. Similar to the other patients with a history of
epileptic seizures, these six patients all showed propagation
between different brain areas in the pre-LEV investigation.
The in-LEV investigations in these patients on the other
hand revealed a mixture of source distributions with and
Table 2 Initial source location and source propagation in all patients before and during LEV treatment
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Fig. 2 Results in Patient 6 who is considered optimally treated with
LEV. Upper part: Raw EEG against a common reference. Middle
part: Time course of the reconstructed cortical activation in the 20
ROIs. Lower part: Source reconstruction of active regions at different
single time points. Colors show source strength within the different
ROIs at the given time point (red strongest activation, green weakest
activation). Red circle: primary activation area, blue circle:
propagation area. Left side = left hemisphere. a Results for one
spike average in the pre-LEV condition. The spike shows propagation
from the right occipital to mainly the left occipito-temporal area.
b Results for one spike average in the in-LEV condition. There is an
important reduction in spike number (not shown) and spike/source
waveform amplitudes compared to the pre-LEV investigation, and a
suppression of the propagation to the left occipito-temporal area
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without propagation (Table 2). As opposed to the previous
group, these six patients were not clinically considered to
be optimally treated. In one of these patients the LEV dose
has been increased, but the effect of this is not yet known.
In the remaining five patients the LEV medication was
considered to be insufficient, and was either supplemented
with nitrazepam (3 cases) or terminated (2 cases).
In summary, 22/24 spikes (92%) in the pre-LEV
investigation of patients with a history of epileptic seizures
showed propagation. In contrast, only 7/15 (47%) of the
spikes in the in-LEV investigation showed propagation,
and six of these seven spikes were recorded in patients with
poor or insufficient effect of the treatment (Table 2).
The results in two of the patients with a history of seizures
are shown in Figs. 2 and 3. In Patient 6 (Fig. 2) the pre-LEV
study shows clear propagation, from the right occipital to
mainly the left occipito-temporal area. Introduction of LEV
gives a marked reduction in spike number and spike
amplitude, and the propagation is suppressed. This patient
is considered optimally treated with LEV. In Patient 12
(Fig. 3), with a left temporo-parietal focus, the spike num-
ber and spike amplitudes are not reduced after introduction
of the drug, but there is a clear suppression of propagation to
bifrontal areas. Based on persisting behaviour abnormalities
and due to the unchanged spike number/amplitude, the
patient was not considered optimally treated, and nitraze-
pam was added.
Patients Without a History of Epileptic Seizures
In the remaining 13 patients (pats 18–30) there was no
history of seizures, and treatment with AEDs was initiated
because the interictal epileptiform activity during sleep was
considered to interfere significantly with the patient’s
cognitive or psychosocial functions. In ten of these patients
the treatment could be considered successful in the sense
that the epileptiform activity completely disappeared after
start of LEV-treatment (pats 18–25), or decreased consid-
erably in number and amplitude (pats 26 and 27). As
opposed to the patients with a seizure history, only four of
the ten patients in this group showed propagation between
different ROIs in the pre-LEV investigation (Table 2), and
the patients showing propagation tended to be those with
the most active epileptic focus (Table 1). In the last three
patients (pats 28–30) the LEV treatment did not manage to
suppress the epileptiform activity, neither in terms of
number of spikes or spike amplitude, and the treatment was
terminated. Similarly to the non successful cases in the
group with seizures, there was for these patients a mixture
of source distributions with and without time lag both in
the pre-LEV and in-LEV investigations (Table 2).
In the non seizure group only 10/23 spikes (43%) in the
pre-LEV recording, and 2/9 spikes (22%) in the in-LEV
recording showed propagation (Table 2). Consequently
there was a tendency for LEV to suppress propagation also
in these patients, although this tendency was obscured by
the fact that fewer of the spikes showed propagation in the
first place.
Discussion
The aim of the present study was to assess the changes in
propagation patterns of the interictal epileptiform activity
when introducing LEV to patients. This was done by means
of Electric Source Imaging. Apart from more intuitively
comprehensible markers of drug efficacy, such as decrease
in number of spikes and decrease in amplitude of the epi-
leptic source, we noted a clear decrease in propagation of
interictal activity between different brain areas as an effect
of drug treatment.
In patients with FNEA the goal of antiepileptic treat-
ment is not only freedom from seizures but also suppres-
sion of the interictal epileptiform activity which is
considered to hamper the patients cognitive functions and
hence, their daily life. It is often observed that successful
treatment with AEDs initially leads to a decrease in number
and amplitude of the interictal spikes, and that subsequent
increase of the dose of the drug may lead to complete
suppression of the epileptiform activity. There may also be
several different epileptic foci that are simultaneously
active, and the most active focus may vary from one
investigation to the next, irrespective of whether any
change in medication has been made. This means that in
this specific patient group, it is difficult to determine
exactly what effect a pharmacological substance has on one
particular focus area. In some of the patients in this study
the focus area was virtually unchanged from pre-LEV to
the in-LEV investigation, whereas in some of the patients
the pre- and post treatment focus locations were completely
different. However, irrespective of whether the focus was
the same before and during treatment or not, the tendency
of this focus to propagate was suppressed by the treatment.
An interesting observation is that propagation between
different brain areas in the pre-LEV EEG, was much more
frequently seen in patients with a history of epileptic sei-
zures. A relation between relative epileptogenicity and the
complexity of focal spikes has also been reported by other
authors (Rodin et al. 1995). We hypothesize that propa-
gation is a feature of a more aggressive and complex dis-
ease. An epileptic seizure is a clinical manifestation of the
electric activity in the brain. The pathological electro-
magnetic activity must comprise enough brain substrate to
give visible symptoms. Hence, propagation of the activity
is a prerequisite in most seizures. The fact that the rather
few patients in the non seizure group that exhibited
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propagation in the pre-LEV study tended to be those with
the most active interictal epileptic focus, also indicates a
relation between tendency for propagation and severity of
the disease. However, since MRI investigations were not
available in all patients this could not be checked in this
study.
It has been suggested that, in many circumstances,
interictal epileptiform discharges can be the result of
inhibitory processes that suppress the interictal-ictal tran-
sition, and that the strong after inhibition produced by
interictal spikes actually protects against the occurence of
ictal activity (De Curtis and Avanzini 2001). If this were
the case, suppression of spike propagation might actually
lower the ictal threshold rather than increasing it, and an
efficient antiepileptic drug should rather be one that
increases the spread of interictal discharges. The rather
clear relation between suppression of spike propagation
and clinical improvement in this study rather talk against
such a protective role of interictal spiking.
In this study we interpret the time difference between
activation of different regions in terms of source propa-
gation. This interpretation can be debated. A complex
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Fig. 3 Results in Patient 12. Upper part: Time course of the
reconstructed cortical activation in the 20 ROIs. Lower part: Source
reconstruction of active regions at different single time points. Colors
show source strength within the different ROIs at the given time point
(red strongest activation, green weakest activation). Red circle:
primary activation area, blue circle: propagation area. a Results for
one spike average in the pre-LEV condition. The primary activation is
in the left temporo-parietal area, but with important propagation to
mainly left, but also right frontal regions. b Results for one spike
average in the in-LEV condition. Compared to the pre-LEV condition
there is no reduction in spike number (not shown) or spike amplitude,
but there is a clear suppression of the bifrontal propagation. Due to
the unchanged spike number/amplitude the patient was not considered
optimally treated, and nitracepam was added
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activation of several independent regions with a certain
time asynchrony would also explain our results. In Pat 10
there is in fact little or no time asynchrony between the
different active regions in the pre-LEV investigation, but
still an important suppression of the activity in several
areas after drug introduction. On the other hand, the areas
that are suppressed by the drug tend to be not the primarily
activated ones, but rather those with a latency with respect
to the primarily activate area. This fact would indicate that
the mechanism is indeed suppression of propagation. In
any case, the results indicate that introduction of LEV
limits the extension of the areas that are activated by the
epileptic process, whether the extended activation is a
result of propagation or not.
An important question is whether the change in propa-
gation is a specific feature of LEV and similar substances,
or whether similar effects might be observed with other
neurotropic drugs with different mechanisms of action.
Some of the patients in this study were indeed treated with
other AEDs (sodium valproate, topiramate and others,
Table 1) at the time of the pre-LEV investigation, but it
was not until levetiracetam treatment was introduced that
the propagation disappeared and improvement in other
EEG and clinical parameters occurred. Even so, although
our study only demonstrates this effect for LEV treatment,
it can not be excluded that what we are observing is the
result of an efficient antiepileptic treatment irrespective of
the type of drug as LEV was introduced due to lack of
effect of prior AED medication.
Another important issue is whether the suppression of
propagation occurs more promptly after administration of
the AED than decrease in spike frequency and amplitude
and, in that case, whether propagation changes could be
used as a marker of acute drug effect, for instance after
administration of a test dose. Another question is to what
extent the pharmacological effect on source propagation is
specific to patients with good results of treatment. In this
study the number of patients with poor effect of LEV
treatment was rather small, and the drug effect on propa-
gation and other parameters in non responders has to be
more thoroughly investigated.
In the present study it was necessary to use data that had
been recorded in a clinical routine setting which leads to
some methodological drawbacks. The limited number of
recording electrodes (16 channels) limits the spatial reso-
lution making source separation on a sub lobar level dif-
ficult (Lantz et al. 2003a). The relatively low sampling rate
(100 Hz) also limits the possibility to visualize fast prop-
agation. In some cases we have noted a propagation latency
of only 10 ms between active areas (Table 2), which is on
the limit of what our methodology allows us to detect.
These factors lead to a rather limited accuracy, both spa-
tially and temporally, of the results. The purpose of this
study, however, was rather to visualize temporal separation
of the activity in different major brain areas, a task which is
less hampered by a limited number of recording electrodes.
In addition, although quite short propagation latencies were
encountered in a few patients, the average latency in the
pre LEV recordings of patient with a seizure history was
above 20 ms (Table 2), which is well within the limits of
what can be detected with a 100 Hz sampling rate. Another
potentially confounding factor is the fact that some of the
patients were treated with other AEDs although, as men-
tioned above, this does not seem to have any major effect
on the parameters we are measuring.
We conclude that it is indeed possible to use ESI to visu-
alize effects of antiepileptic medication on the interictal epi-
leptiform activity, and the findings seem to be rather stable
also in individual patients. We suggest that changes in the
tendency of an epileptic focus to propagate between different
brain regions could be used as an additional parameter when
judging the efficacy of AED treatment, and this technique
might thus become a useful tool in the evaluation of new
candidate drugs in pharmacological development.
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